Pharma/Biotech - Page 1 | TalkMarkets

Blogs

All Posts > Content under Pharma/Biotech
1 to 16 of 3050 Posts
1 2 3 ... 191
E Market Briefing For Thursday, February 20
Article By: Gene Inger
Thursday, February 20, 2020 3:54 AM EST
Persistent 'top-heavy' dominance - of the S&P continues churning-out higher highs, irrespective of growth downgrades anticipated, while some other stocks, with actual growth potential, languish relatively.
In this article: AMD, AMRN, LPTH, NYA
Read
5 Drug/Biotech Stocks Likely To Beat Q4 Earnings Estimates
Article By: Zacks Investment Research
Monday, February 17, 2020 10:34 AM EST
The Medical sector has witnessed a fairly good run in this earnings cycle so far.
In this article: IMMU, CLVS, PRGO, VTVT, ETON Also: JNJ, GILD
Read
Healthcare (Top 30 Weights) Earnings Estimates And Revisions
Article By: T.J. Hayes
Monday, February 17, 2020 5:44 AM EST
The cumulative 2020 earnings power of these 30 stocks was revised down by -.34% in the past 60 days.
In this article: EW, HCA, HUM, JNJ, LLY, MDT, MRK, PFE, SYK, TMO, UNH, ILMN, AMGN, BIIB, GILD, ISRG, VRTX Also: ABT, AGN, BAX, BDX, BMY, BSX, CI, CNC, CVS, DHR, XLV, ZTS, ABBV, ANTM
Read
Paulson Adds Pretium, Exits United Tech In Q4
Article By: The Fly
Sunday, February 16, 2020 12:29 PM EST
John Paulson's Paulson & Co. disclosed in an SEC filing its holdings as of December 31, 2019. The fund's top holdings as of December 31, in order of size, were Bausch Health, SPDR Gold Shares, Allergan, Discovery Class C and Horizon Therapeutics
In this article: AGN, CPE, PCG, QEP, S, TIF, UTX, LOGM, DISCK, GOLD, HZNP, TECD, GLD, PVG, CZR, BHC, NMRK, INSW, LYFT
Read
Alkermes Targets Bipolar Disorder And Schizophrenia
Article By: MoneyShow.com
Sunday, February 16, 2020 11:52 AM EST
We strongly recommend that investors take advantage of the weakness and buy Alkermes, whose treatment of schizophrenia and bipolar disorder has been accepted by the FDA for review.
In this article: ALKS Also: BIIB, MYL
Read
E US Stock Market Weekly Update February 10 - February 14, 2020
Article By: Stavros Georgiadis
Sunday, February 16, 2020 8:48 AM EST
The attention of the global financial markets and the US stock market remains on the current outbreak of coronavirus disease and latest news and developments.
In this article: TRT, SPCE, GNPX, BNTC, PAVMW, CCR
Read
Week In Review: Bio-Thera Raises $241 Million In Shanghai STAR IPO For Antibody Portfolio
Article By: ChinaBio® Today
Saturday, February 15, 2020 4:19 PM EST
Bio-Thera Solutions of Guangzhou priced its IPO on Shanghai’s STAR Board to raise $241 million at a valuation of almost $2 billion. The offering, which placed 60 million shares at RMB32.76 each, was reported to be 3,225 times oversubscribed.
In this article: JNJ, ROG, GILD, ZLAB
Read
Aptose Biosciences - Chart Of The Day
Article By: Jim Van Meerten
Friday, February 14, 2020 2:43 PM EST
Aptose Biosciences Inc. is a clinical-stage biotechnology company.
Read
E Canopy Growth Reports Very Positive Q3 Results - Stock Jumps
Article By: Lorimer Wilson
Friday, February 14, 2020 12:35 PM EST
Canopy Growth Corporation today announced its financial results for the third quarter ended December 31, 2019, and stock jumps.
In this article: CGC Also: ACB
Read
E Aurora Cannabis Q2 2020 Results Show Declines Across The Board
Article By: Lorimer Wilson
Thursday, February 13, 2020 7:00 AM EST
Aurora reiterates its outlook for Q3 that cannabis revenue will be impacted by industry headwinds, and as such will likely show modest to no growth relative to fiscal Q2's cannabis revenue.
In this article: ACB
Read
Teva Reports Q4 Earnings Beat
Article By: Benzinga
Wednesday, February 12, 2020 8:54 AM EST
Teva Pharmaceutical Indus reported fourth-quarter earnings of 64 cents per share, which beat the analyst consensus estimate of 61 cents by 4.92%.
Read
Large Cap Biopharmaceutical Companies-Metrics And Valuations…
Article By: Rod Raynovich
Wednesday, February 12, 2020 1:00 AM EST
The IBB is at $122.69 near the 52 week high but short of 5 year high of $132.53 from Jy ’15.
In this article: BMY, MRK, RHHBY, ABBV, CELG, IBB, VRTX, ALXN, BIIB, XLV
Read
Mid-Day Market Update: Amkor Technology Surges On Upbeat Q4 Results; Phio Pharmaceuticals Shares Plummet
Article By: Benzinga
Tuesday, February 11, 2020 1:03 PM EST
Midway through trading Tuesday, the Dow traded up 0.19% to 29,333.28 while the NASDAQ rose 0.8% to 9,705.16. The S&P also rose, gaining 0.54% to 3,370.08.
In this article: S, AMKR, SBAC, UNIT, MYO
Read
E Inovio Pharmaceuticals: 2020 Is The Make Or Break Year
Article By: Sunil Tinani
Monday, February 10, 2020 10:52 AM EST
Inovio Pharmaceuticals has been a non-performer on the charts as it has yet to breakthrough the markets, and because of its rich valuations. However, 2020 offers hope and can prove to be a turnaround year.
In this article: INO Also: JNJ, NVAX, MRNA
Read
Biohaven Shares Should Not Be Down This Much On Study Miss, Says Piper Sandler
Article By: The Fly
Monday, February 10, 2020 10:03 AM EST
Piper Sandler analyst Tyler Van Buren keeps an Overweight rating on Biohaven Pharmaceutical with a $100 price target.
In this article: BHVN
Read
Biotech Stock Segment Going Bananas In February 2020
Article By: Taki Tsaklanos
Sunday, February 9, 2020 2:37 PM EST
One sector that is going crazy is the biotech stock sector. One thing we do know about markets that go bananas: if it’s unclear what their intention is you better stay at the sidelines.
In this article: IBB
Read
1 to 16 of 3050 Posts
1 2 3 ... 191